介入性神經放射學市場規模、佔有率和成長分析：按組件、疾病狀態、最終用戶和地區分類－2026-2033年產業預測

2024 年全球介入性神經放射學市場價值為 28 億美元，預計從 2025 年的 33.6 億美元成長到 2033 年的 145.6 億美元，預測期（2026-2033 年）的複合年成長率為 20.1%。

全球介入性神經放射學市場日益重要，因為它為腦血管疾病提供了微創治療方案，為傳統開放性手術提供了一種替代方案。隨著中風、顱內動脈瘤和動靜脈畸形等疾病發病率的上升，有效且快速的治療對於降低發病率和醫療成本至關重要。該市場的成長主要得益於保險報銷政策的改善，這些政策減輕了醫院和患者的經濟負擔，並增加了手術量。保險公司對血管內治療成本效益的認知不斷提高，正在擴大關鍵設備的保險覆蓋範圍。此外，人工智慧和物聯網的進步正在提高患者安全性，實現即時數據分析和潛在併發症的預測預警，簡化手術流程，並增強人們對高風險神經血管介入治療的信心。

全球神經放射介入市場按組件、疾病類型、最終用戶和地區進行細分。依組件分類，市場分為栓塞裝置、神經血栓切除裝置、輔助裝置、通路裝置和SaaS（軟體即服務）平台。依疾病類型分類，市場分為顱內動脈瘤、動靜脈畸形、急性缺血性腦中風和頸動脈疾病。依最終用戶分類，市場分為醫院、門診手術中心和專科診所。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球介入性神經放射學市場的成長要素

對微創治療日益成長的需求正在推動介入性神經放射學市場的發展。患者和醫療專業人員都支持能夠縮短住院時間、降低併發症風險並加速復原的治療方法。導管技術創新與先進影像技術的結合，實現了在腦血管內精準導航，使得在門診治療以往複雜的疾病（例如動脈瘤和中風）成為可能。這項臨床優勢不僅推動了各個醫學專科對介入治療的廣泛應用，也導致手術數量的增加，促使企業投資建設專業的介入神經放射學治療設施，並進一步加速市場擴張。隨著治療效果的提升，轉診率不斷上升，醫療機構也紛紛建立專門的介入神經放射學科室。

全球介入神經放射學市場的限制因素

全球介入神經放射學市場面臨嚴峻挑戰，主要原因是專用血管造影術室、機器人輔助系統和高解析度影像設備需要大量的初期投資。發展中地區的小規模診所和醫院往往由於資金籌措有限和投資回收期長而難以開展介入神經放射學項目，從而造成沉重的經濟負擔。因此，儘管臨床需求持續成長且技術不斷進步，但管理者往往傾向於選擇更具成本效益的服務，這阻礙了介入性神經放射學在預算緊張地區的市場滲透。因此，許多醫療機構推遲了對現有導管檢查室的升級改造，轉而選擇前期投資較低的傳統外科手術方法。

介入性神經放射學的全球市場趨勢

全球介入神經放射學市場正經歷一場重大變革，而人工智慧影像技術的整合正是推動這項變革的動力。這些創新技術提高了影像處理的速度和精度，實現了病灶的即時檢測和導管的精準導航，同時最大限度地減少了輻射暴露——輻射暴露是該領域的主要關注點。臨床醫生擴大利用深度學習模型來最佳化手術方案並制定個人化的治療策略，從而促進更可預測的患者照護。這一趨勢正在推動醫療設備製造商、軟體開發商和臨床中心之間形成協作生態系統，加速先進成像平台在領先醫院的應用，並持續改善患者的治療效果。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球介入性神經放射學市場規模：按組成部分分類

• 栓塞裝置
• 神經血栓除去裝置
• 輔助設備
• 存取裝置
• SaaS平台

全球介入性神經放射學市場規模：依病理類型分類

• 顱內動脈瘤
• 動靜脈畸形
• 急性缺血性腦中風
• 頸動脈疾病

全球介入性神經放射學市場規模：依最終用戶分類

• 醫院
• 門診手術中心
• 專科診所

全球介入性神經放射學市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Coloplast AS
• Getinge AB
• Penumbra Inc
• Johnson and Johnson MedTech
• Terumo Corporation
• MicroVention Inc
• Balt USA LLC
• Micrus Endovascular Corporation
• Acandis GmbH
• Phenox GmbH
• Rapid Medical Ltd
• Siemens Healthineers AG
• GE HealthCare Technologies Inc
• Koninklijke Philips NV
• Mallinckrodt Medical Inc
• Mediview XR Inc
• Xironetic Inc
• Scopis GmbH
• Realize Medical Inc
• Genesis MedTech International Inc

結論與建議

Global Interventional Neuroradiology Market size was valued at USD 2.8 Billion in 2024 and is poised to grow from USD 3.36 Billion in 2025 to USD 14.56 Billion by 2033, growing at a CAGR of 20.1% during the forecast period (2026-2033).

The global interventional neuroradiology market is increasingly vital due to its minimally invasive solutions for cerebrovascular disorders, offering alternatives to open surgery. As the incidence of conditions like strokes, intracranial aneurysms, and arteriovenous malformations rises, effective and timely management becomes critical to reducing morbidity and healthcare costs. The growth of this market is significantly fueled by improved reimbursement policies, which alleviate financial pressures on hospitals and patients, increasing procedure rates. Recognition by insurers of the cost-effectiveness of endovascular treatments fosters wider coverage for essential devices. Also, advancements in AI and IoT are enhancing patient safety, enabling real-time data analysis, and predictive warnings for potential complications, streamlining procedures, and boosting confidence in high-stakes neurovascular interventions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Interventional Neuroradiology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Interventional Neuroradiology Market Segments Analysis

The global interventional neuroradiology market is segmented by component, pathology type, end user and region. Based on component, the market is segmented into Embolization Devices, Neurothrombectomy Devices, Support Devices, Access Devices and Software as a Service Platforms. Based on pathology type, the market is segmented into Intracranial Aneurysms, Arteriovenous Malformations, Acute Ischemic Stroke and Carotid Artery Disease. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Interventional Neuroradiology Market

The increasing desire for minimally invasive therapeutic options is fueling the growth of the interventional neuroradiology market. Patients and healthcare professionals alike are advocating for procedures that minimize hospital stays, lower the risks of complications, and facilitate quicker recovery times. Innovations in catheter technology coupled with advanced imaging techniques enable accurate navigation within cerebral vessels, making previously complex aneurysm and stroke treatments feasible in an outpatient setting. This clinical advantage not only promotes wider adoption across various medical specialties but also boosts procedural volumes, prompting companies to invest in specialized neuro-intervention facilities that further accelerate market expansion. As perceived outcomes improve, referral rates rise, leading institutions to establish dedicated neuro-intervention units.

Restraints in the Global Interventional Neuroradiology Market

The Global Interventional Neuroradiology market faces significant challenges due to the substantial initial investment required for specialized angiography suites, robotic assistance, and high-definition imaging equipment. Smaller clinics and hospitals in developing regions often struggle to implement interventional neuroradiology programs due to limited financing options and extended payback periods, creating financial strain. As a result, administrators frequently opt for more cost-effective services, impeding market penetration in budget-constrained areas despite persistent clinical demand and technological advancements. Consequently, many institutions postpone upgrades to existing catheterization labs, choosing conventional surgical methods that necessitate less upfront capital investment instead.

Market Trends of the Global Interventional Neuroradiology Market

The Global Interventional Neuroradiology market is witnessing a significant transformation driven by the integration of AI-driven imaging technologies. By enhancing the speed and accuracy of image processing, these advancements facilitate immediate lesion detection and precise catheter navigation, while simultaneously minimizing radiation exposure-a critical concern in the field. Clinicians increasingly leverage deep learning models to refine procedure planning and customize treatment strategies, fostering a more predictive approach to patient care. This trend is also promoting a collaborative ecosystem among device manufacturers, software developers, and clinical centers, accelerating the adoption of advanced imaging platforms in major hospitals and leading to continuous improvements in patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Interventional Neuroradiology Market Size by Component & CAGR (2026-2033)

• Market Overview
• Embolization Devices
• Neurothrombectomy Devices
• Support Devices
• Access Devices
• Software as a Service Platforms

Global Interventional Neuroradiology Market Size by Pathology Type & CAGR (2026-2033)

• Market Overview
• Intracranial Aneurysms
• Arteriovenous Malformations
• Acute Ischemic Stroke
• Carotid Artery Disease

Global Interventional Neuroradiology Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Global Interventional Neuroradiology Market Size & CAGR (2026-2033)

• North America (Component, Pathology Type, End User)
  • US
  • Canada
• Europe (Component, Pathology Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Pathology Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Pathology Type, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Pathology Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Coloplast AS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson and Johnson MedTech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroVention Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balt USA LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micrus Endovascular Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phenox GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Medical Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare Technologies Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips NV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Medical Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediview XR Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xironetic Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scopis GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Realize Medical Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genesis MedTech International Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations